Can Cancer Be Treated While Breast Cancer With Liver Metastasis Is In Remission?
Question: In 2000 I had triple neg breast cancer treated w/radiation and tamoxifin, then arimidex - In 2016 triple negative - mast. left breast - then metastis to liver - 3 lesions removed - 1 cancerous and ultra sound of liver - great shape - 17 lymph nodes removed - 1 cancerous -
Treated w/4 rounds of carboplatin and taxol 4 rounds after 1st mast. - then genzar 4 rounds - Removed lesions from liver and lymphnodes - cancer free at this point in time - what would be the recommended follow up treatment.
Treated w/4 rounds of carboplatin and taxol 4 rounds after 1st mast. - then genzar 4 rounds - Removed lesions from liver and lymphnodes - cancer free at this point in time - what would be the recommended follow up treatment.
Brief Answer:
Hello. Wait and watch
Detailed Answer:
Hello dear. I have gone through the details. So if there is no tumor in body, ideal approach would be to wait and watch till disease reappear and then fo chemo again. Another option is to use oral drugs like capecitabine and methotrexare. You can discuss these options with your doctor.
Another experimental option would be to use immunotherapy.
Thanks and regards
Hello. Wait and watch
Detailed Answer:
Hello dear. I have gone through the details. So if there is no tumor in body, ideal approach would be to wait and watch till disease reappear and then fo chemo again. Another option is to use oral drugs like capecitabine and methotrexare. You can discuss these options with your doctor.
Another experimental option would be to use immunotherapy.
Thanks and regards
Above answer was peer-reviewed by :
Dr. Prasad
Sorry I made a mistake in 2000 I had Estrogen Positive cancer, lumpectomy & radiation tamoxifin for approx. 6 mos. - unable to tolerate tamoxifin so placed on arimidex. - in 2016 when it recurred it was triple negative. I assume your answer would be the same.
Brief Answer:
Yes, the approach remains same
Detailed Answer:
Hello dear.
So the current receptor status matters and in triple negative, the approach is same as I mentioned earlier.
Thanks and regards
Yes, the approach remains same
Detailed Answer:
Hello dear.
So the current receptor status matters and in triple negative, the approach is same as I mentioned earlier.
Thanks and regards
Note: For further queries related to kidney problems Click here.
Above answer was peer-reviewed by :
Dr. Arnab Banerjee